# Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer

> **NCT00887640** · PHASE2 · TERMINATED · sponsor: **Duke University** · enrollment: 11 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Temsirolimus
- **DRUG:** Diphenhydramine

## Key facts

- **NCT ID:** NCT00887640
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2014-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00887640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00887640, "Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00887640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*